Stay updated on SL-401 Combo in AML/MDS/BPDCN Clinical Trial
Sign up to get notified when there's something new on the SL-401 Combo in AML/MDS/BPDCN Clinical Trial page.

Latest updates to the SL-401 Combo in AML/MDS/BPDCN Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedDifference0.8%
- Check19 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.7%
- Check27 days agoChange DetectedDifference0.9%
- Check34 days agoChange DetectedThe page has been updated to reflect a new version of the clinical trial information, including the addition of collaborators and the principal investigator's name. Significant details about the study's focus on Acute Myeloid Leukemia and related conditions remain, but extensive descriptions of the study's methodology and criteria have been removed.SummaryDifference40%
- Check41 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference1%
- Check49 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.6%
Stay in the know with updates to SL-401 Combo in AML/MDS/BPDCN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SL-401 Combo in AML/MDS/BPDCN Clinical Trial page.